Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 4.53B 668M 583M 538M 496M 935M 64.3B 956M 6.44B 2.53B 31.49B 2.51B 2.45B 108B P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 4.36B 643M 562M 518M 478M 901M 61.9B 920M 6.2B 2.44B 30.32B 2.41B 2.36B 104B EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day-9.11%
1 week-5.01%
Current month+1.43%
1 month+3.05%
3 months-22.82%
6 months-15.53%
Current year-2.02%
1 week 7.77
Extreme 7.77
8.78
1 month 7.08
Extreme 7.08
8.78
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.98
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
15.59
Manager TitleAgeSince
Chief Executive Officer 42 10/12/2017
Director of Finance/CFO 34 31/07/2019
Chief Operating Officer 45 24/08/2022
Director TitleAgeSince
Chairman 42 31/07/2019
Chairman 48 20/03/2019
Director/Board Member 46 20/03/2019
Date Insider Type Main position Quantity % Market Cap.
14/09/21 Sell

Executive/Senior Manager

10,000 0.0025%
10/09/21 Sell

Executive/Senior Manager

77,000 0.0189%
09/06/21 Sell

Executive/Senior Manager

60,000 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
-9.11%-5.01%-14.22%+17.52% 668M
+0.85%-0.80%+54.84%+163.70% 1,051B
+1.23%-1.53%+55.26%+59.07% 609B
+0.04%+2.58%+32.96%+88.75% 450B
+0.78%-0.71%+30.04%+24.61% 330B
+1.41%+0.58%+33.92%+47.20% 284B
-0.27%-1.87%+22.13%+23.47% 263B
-1.76%+2.37%-22.19%-38.45% 223B
-1.42%+0.80%+22.81%+60.77% 198B
-1.48%+3.43%+23.42%+73.31% 167B
Average -1.02%+0.15%+23.90%+51.99% 357.57B
Weighted average by Cap. +0.21%+0.02%+37.74%+81.48%

Financials

2024 2025
Net sales 984M 145M 127M 117M 108M 203M 13.97B 208M 1.4B 550M 6.84B 545M 533M 23.56B 1.21B 178M 155M 143M 132M 249M 17.12B 255M 1.71B 674M 8.39B 668M 653M 28.87B
Net income 13.65M 2.01M 1.76M 1.62M 1.5M 2.82M 194M 2.88M 19.41M 7.64M 94.99M 7.56M 7.4M 327M 92.73M 13.68M 11.96M 11.03M 10.17M 19.17M 1.32B 19.59M 132M 51.87M 645M 51.38M 50.25M 2.22B
Net Debt 189M 27.9M 24.38M 22.5M 20.74M 39.08M 2.69B 39.95M 269M 106M 1.32B 105M 102M 4.53B -169M -24.91M -21.76M -20.08M -18.51M -34.89M -2.4B -35.67M -240M -94.42M -1.17B -93.53M -91.48M -4.04B
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
17/07/26 CN¥7.780 -9.11% 32,009,188
16/07/26 CN¥8.560 -0.47% 29,806,900
15/07/26 CN¥8.600 +4.24% 38,916,877
14/07/26 CN¥8.250 +2.48% 20,919,854
13/07/26 CN¥8.050 -1.71% 19,387,650

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300016 Stock